Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 -0.02 (-5.09%)
As of: Oct 21, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Work In Process (2024 - 2026)

Updated

Citius Pharmaceuticals (CTXR) recorded Work In Process of $6.95 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Work In Process (2024 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Work In Process of $11.71 million, up 448.7% from FY2024.

  • Across earlier fiscal years, Work In Process came in at $2.13 million in FY2024.
  • Quarterly Work In Process has ranged from $2.13 million in fiscal Q4 2024 to $11.71 million in fiscal Q4 2025 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $6.95 million (Q2 2026), $6.95 million (Q1 2026) and $11.71 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.37 Mn -23.20 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.95 Mn
Mar 31, 2026 6.95 Mn
Dec 31, 2025 6.95 Mn
Sep 30, 2025 11.71 Mn
Sep 30, 2024 2.13 Mn
API Access

Citius Pharmaceuticals Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=CTXR&period=max&api_key=YOUR_API_KEY